CEO sold ~$4.2M of Northrop Grumman
Scheduled in advanceTraded Dec 9, 2025 · Filed Dec 11, 2025
Sold under a plan set up in advance, so the timing wasn't a fresh decision
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$46,649
Shares × reported transaction price
49 days after results of Oct 21, 2025, 49 days before results of Jan 27, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $550.63 on Dec 9, 2025, 27% above its 52-week low and 14% below its high, after an 8% drop over the previous 30 trading days
52-week range $433.45 (Feb 19, 2025) to $637.95 (Oct 8, 2025), 57% of the way up, from 250 adjusted closes. 30 trading days earlier: $595.95 on Oct 27, 2025. Describes the past only, not a forecast
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | -0.2% | -0.2% | -0.1% |
| 30 days | +10.4% | +2.0% | +8.5% |
| 90 days | +29.2% | -2.3% | +31.5% |
| 180 days | -4.8% | +6.4% | -11.3% |
Past results only. Not a forecast.
CEO sold ~$4.2M of Northrop Grumman
Scheduled in advanceCEO sold ~$1.84M of Northrop Grumman
Scheduled in advanceCompensation award — excluded from discretionary-purchase analysis.